Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oramed Pharmaceuticals (ORMP) Cash from Operations (2022 - 2025)

Oramed Pharmaceuticals' Cash from Operations history spans 4 years, with the latest figure at 2644000.0 for Q4 2025.

  • For Q4 2025, Cash from Operations changed N/A year-over-year to 2644000.0; the TTM value through Dec 2025 reached 11188000.0, changed N/A, while the annual FY2025 figure was 9145000.0, 8.71% down from the prior year.
  • Cash from Operations reached 2644000.0 in Q4 2025 per ORMP's latest filing, up from 3519000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 2076000.0 in Q2 2024 to a low of 9125000.0 in Q1 2022.
  • Average Cash from Operations over 4 years is 3913615.38, with a median of 2644000.0 recorded in 2025.
  • The largest YoY upside for Cash from Operations was 178.82% in 2024 against a maximum downside of 923.2% in 2024.
  • A 4-year view of Cash from Operations shows it stood at 8062000.0 in 2022, then surged by 82.41% to 1418000.0 in 2023, then tumbled by 400.78% to 7101000.0 in 2024, then surged by 62.77% to 2644000.0 in 2025.
  • Per Business Quant, the three most recent readings for ORMP's Cash from Operations are 2644000.0 (Q4 2025), 3519000.0 (Q1 2025), and 7101000.0 (Q3 2024).